/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo

Developments

Topic

Latest Stories

Person to Person
1.30.20, 2:12 PM EST on neoscope
CDC Confirms First US Person-to-Person Coronavirus Transmission
Terrible Screenplay
1.30.20, 12:09 PM EST on neoscope
A Cruise Ship Was Stranded at Sea Due to Coronavirus Risk
Demographic Break...
1.28.20, 3:50 PM EST on neoscope
The Coronavirus Outbreak is Most Dangerous for the Elderly
Game Over
1.28.20, 1:30 PM EST on neoscope
Makers of "Plague Inc." Game: Get Your Coronavirus Info Elsewhere
Event 201
Updated 1.27.20, 5:33 PM EST on neoscope
In a Recent Simulation, a Coronavirus Killed 65 Million People
Global Impact
1.27.20, 11:36 AM EST on neoscope
Reports of Coronavirus Outbreak Hit Every Inhabited Continent
Grim Outlook
Updated 1.24.20, 5:36 PM EST on neoscope
Virologist: China Virus Will Be At Least 10x Worse Than SARS
Eurotrip
1.24.20, 5:20 PM EST on neoscope
The Mysterious Chinese Outbreak Just Reached Europe
Total Lockdown
Updated 1.24.20, 3:17 PM EST on neoscope
China Has Now Quarantined 35 Million People to Prevent Pandemic
Going Viral
1.24.20, 1:41 PM EST on neoscope
CDC Confirms Second Chinese Virus Case in the US
Unknown Pathogen
Updated 1.23.20, 2:52 PM EST on neoscope
A Strange Disease Is Sweeping China
New Cases
Updated 1.23.20, 2:51 PM EST on neoscope
China's Mysterious Virus Spreads to Japan and Thailand
  • Previous
  • 1
  • ...
  • 75
  • 76
  • 77
  • ...
  • 81
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.